Warrington in the News Articles: page 1

It’s no secret that Warrington faculty are internationally renowned for their innovative research. The media looks to our scholars for insights and impactful news. See below where our faculty are featured in the news.

Page:
audit concept. Businessman with magnifying glass and financial statements. High quality photo

Research from Fisher School of Accounting Assistant Professors Michael Ricci and Dan Rimkus shows that despite young auditors adeptly identifying uncooperative clients as suspicious, they struggle to confront them for more information.

Uncooperative clients can undermine audit quality, according to new study

UF News
Jay Ritter

Jay Ritter comments on this story about Warren Buffett’s legacy. The Berkshire Hathaway CEO announced that he would be stepping down at the end of the year in favor of his long-designated successor, Greg Abel.

Warren Buffett’s legacy: fantastic returns and a troubling precedent

Financial Times
Jay Ritter

Trump Media & Technology Group (TMTG) has been on a tear in recent weeks, as the president’s company has begun touting increasing fundamental strengths beyond its association with the president. The stock closed at $26.14 on Friday, up 57 percent from this month’s low of $16.66 on April 8. Jay Ritter told Newsweek that TMTG’s recent rise was due to the “pivot into financial services,” which has been in the works since the end of January.

Trump Media Stock Jumps 57%

Newsweek
Jay Ritter

Nomura Holdings Inc. is telling clients to stay invested through the turmoil that’s pervaded financial markets during the escalating trade tensions. With its $1.8 billion acquisition of an asset management business, the Japanese brokerage is putting its money where its mouth is. Jay Ritter shares his insights.

Nomura Bets Big on US Market Rebound With $1.8 Billion Deal

Bloomberg
Jay Ritter

President Donald Trump’s tariff war has hammered stocks and bonds, and shuttered the traditional IPO market. Yet even with risk appetite on hold, the area that could benefit most from the rampant volatility is among the most speculative: The SPAC market. Jay Ritter comments.

SPACs Set to Capitalize on IPO Freeze With $1 Billion Deal Burst

Bloomberg
Jay Ritter

The slow collapse of John Ruiz’s insurance claims company appears to be nearing its end. MSP Recovery, helmed by the brash attorney and University of Miami athletics booster, admitted that it has “substantial doubt” about its ability to continue to operate beyond the next year, according to its 2024 annual report filed this week with the Securities and Exchange Commission. Jay Ritter comments.

 

UM booster John Ruiz’s company says it could close within a year

Miami Herald
Paige Clausen taking a basketball shot on the court.

Combining sports prowess with business acumen, student-athletes at the University of Florida are maximizing their earning potential with master’s degrees in business.

Specializing in everything from finance to management to entrepreneurship in the Warrington College of Business, students like Paige Clausen, Bennett Andersen, and Alberto and Alfonso Mestre are learning how to build their own brands as they progress in their athletic careers.

Student-athletes at UF power their futures with business master's degrees

UF News
Jay Ritter

Going public is not a decision any company takes lightly. For complex, high-revenue businesses in particular, an IPO filing reliably requires years of preparation and hefty investment. Over the past couple weeks, as we’ve seen Klarna, StubHub and others delay scheduled pre-IPO roadshows, it appears markets are to blame. Jay Ritter shares his insights for this story.

The longer IPOs delay, the less likely debuts will happen

Crunchbase
Jay Ritter

Newsweek has mapped the five easiest and five hardest U.S. states to save money in, based on a new study by Bankrate analyzing financial conditions across the nation. Jay Ritter shares his insights on the rankings.

Map Reveals Top 5 Easiest and Hardest States to Save Money In

Newsweek
Jay Ritter

The generic drug maker started with cheeky ads selling knockoff Viagra. Now it’s trying to fend off big drugmakers and navigate a critical government ruling to defend a high-growth line of revenue. Jay Ritter comments on how Hims’ SPAC has impacted its business.

Hims & Hers, at a crossroads, wants to be the Netflix of healthcare

Sherwood
Page: